Stocks · Health care · Biological Products, (No Diagnostic Substances)

Krystal Biotech, Inc.

KRYS Clue Score76
United States Fiscal year ends December CIK 0001711279
331.61
+1.32%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
331.61 on 9 Oct 2026
378 281 185 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $184.74 14 Oct 2025 $188.05 15 Oct 2025 $192.99 16 Oct 2025 $188.33 17 Oct 2025 $190.23 20 Oct 2025 $195.96 21 Oct 2025 $190.78 22 Oct 2025 $186.42 23 Oct 2025 $186.45 24 Oct 2025 $186.13 27 Oct 2025 $189.93 28 Oct 2025 $189.65 29 Oct 2025 $185.05 30 Oct 2025 $189.08 31 Oct 2025 $197.51 3 Nov 2025 $197.85 4 Nov 2025 $203.26 5 Nov 2025 $199.88 6 Nov 2025 $199.97 7 Nov 2025 $197.93 10 Nov 2025 $199.53 11 Nov 2025 $203.00 12 Nov 2025 $203.03 13 Nov 2025 $201.21 14 Nov 2025 $206.16 17 Nov 2025 $208.25 18 Nov 2025 $204.74 19 Nov 2025 $204.10 20 Nov 2025 $204.23 21 Nov 2025 $212.02 24 Nov 2025 $214.89 25 Nov 2025 $216.97 26 Nov 2025 $218.70 28 Nov 2025 $218.00 1 Dec 2025 $215.11 2 Dec 2025 $215.06 3 Dec 2025 $217.46 4 Dec 2025 $221.96 5 Dec 2025 $234.13 8 Dec 2025 $234.05 9 Dec 2025 $234.64 10 Dec 2025 $239.72 11 Dec 2025 $246.78 12 Dec 2025 $244.65 15 Dec 2025 $242.98 16 Dec 2025 $238.55 17 Dec 2025 $235.80 18 Dec 2025 $233.37 19 Dec 2025 $240.80 22 Dec 2025 $249.61 23 Dec 2025 $253.36 24 Dec 2025 $251.29 26 Dec 2025 $252.17 29 Dec 2025 $253.68 30 Dec 2025 $247.88 31 Dec 2025 $246.54 2 Jan 2026 $246.91 5 Jan 2026 $244.71 6 Jan 2026 $249.39 7 Jan 2026 $246.37 8 Jan 2026 $248.91 9 Jan 2026 $261.41 12 Jan 2026 $272.13 13 Jan 2026 $291.93 14 Jan 2026 $291.79 15 Jan 2026 $282.01 16 Jan 2026 $285.04 20 Jan 2026 $274.81 21 Jan 2026 $286.00 22 Jan 2026 $289.13 23 Jan 2026 $281.53 26 Jan 2026 $278.75 27 Jan 2026 $277.36 28 Jan 2026 $272.91 29 Jan 2026 $279.34 30 Jan 2026 $279.24 2 Feb 2026 $282.27 3 Feb 2026 $279.57 4 Feb 2026 $269.13 5 Feb 2026 $267.64 6 Feb 2026 $272.74 9 Feb 2026 $272.61 10 Feb 2026 $270.70 11 Feb 2026 $272.65 12 Feb 2026 $270.26 13 Feb 2026 $276.45 17 Feb 2026 $287.84 18 Feb 2026 $283.29 19 Feb 2026 $262.67 20 Feb 2026 $261.80 23 Feb 2026 $274.59 24 Feb 2026 $266.90 25 Feb 2026 $272.50 26 Feb 2026 $276.36 27 Feb 2026 $275.64 2 Mar 2026 $258.81 3 Mar 2026 $263.80 4 Mar 2026 $265.00 5 Mar 2026 $260.33 6 Mar 2026 $253.69 9 Mar 2026 $258.65 10 Mar 2026 $261.08 11 Mar 2026 $255.00 12 Mar 2026 $251.31 13 Mar 2026 $247.26 16 Mar 2026 $250.16 17 Mar 2026 $256.33 18 Mar 2026 $250.83 19 Mar 2026 $258.00 20 Mar 2026 $251.68 23 Mar 2026 $250.08 24 Mar 2026 $247.09 25 Mar 2026 $254.95 26 Mar 2026 $251.40 27 Mar 2026 $245.39 30 Mar 2026 $246.94 31 Mar 2026 $258.32 1 Apr 2026 $258.91 2 Apr 2026 $260.95 6 Apr 2026 $261.80 7 Apr 2026 $263.99 8 Apr 2026 $264.22 9 Apr 2026 $258.33 10 Apr 2026 $259.00 13 Apr 2026 $267.41 14 Apr 2026 $270.00 15 Apr 2026 $268.54 16 Apr 2026 $264.06 17 Apr 2026 $274.21 20 Apr 2026 $276.50 21 Apr 2026 $272.66 22 Apr 2026 $275.94 23 Apr 2026 $268.04 24 Apr 2026 $272.52 27 Apr 2026 $272.75 28 Apr 2026 $269.27 29 Apr 2026 $259.95 30 Apr 2026 $262.26 1 May 2026 $266.04 4 May 2026 $286.95 5 May 2026 $284.57 6 May 2026 $288.99 7 May 2026 $296.70 8 May 2026 $305.71 11 May 2026 $312.88 12 May 2026 $310.31 13 May 2026 $312.58 14 May 2026 $316.30 15 May 2026 $306.29 18 May 2026 $291.75 19 May 2026 $293.30 20 May 2026 $302.05 21 May 2026 $304.23 22 May 2026 $299.45 26 May 2026 $302.68 27 May 2026 $306.63 28 May 2026 $310.30 29 May 2026 $309.03 1 Jun 2026 $298.10 2 Jun 2026 $293.21 3 Jun 2026 $301.82 4 Jun 2026 $307.79 5 Jun 2026 $301.00 8 Jun 2026 $301.76 9 Jun 2026 $309.75 10 Jun 2026 $312.41 11 Jun 2026 $321.55 12 Jun 2026 $317.97 15 Jun 2026 $324.75 16 Jun 2026 $323.37 17 Jun 2026 $341.66 18 Jun 2026 $348.06 22 Jun 2026 $343.43 23 Jun 2026 $340.21 24 Jun 2026 $347.63 25 Jun 2026 $359.93 26 Jun 2026 $372.25 29 Jun 2026 $378.15 30 Jun 2026 $371.67 1 Jul 2026 $371.58 2 Jul 2026 $375.07 6 Jul 2026 $374.68 7 Jul 2026 $368.60 8 Jul 2026 $375.40 9 Jul 2026 $371.24 10 Jul 2026 $365.81 13 Jul 2026 $363.44 14 Jul 2026 $339.43 15 Jul 2026 $350.24 16 Jul 2026 $341.79 17 Jul 2026 $354.86 20 Jul 2026 $339.22 21 Jul 2026 $339.06 22 Jul 2026 $336.80 23 Jul 2026 $327.50 24 Jul 2026 $335.19 27 Jul 2026 $351.82 28 Jul 2026 $364.23 29 Jul 2026 $363.28 30 Jul 2026 $366.85 31 Jul 2026 $341.12 3 Aug 2026 $312.57 4 Aug 2026 $324.77 5 Aug 2026 $325.78 6 Aug 2026 $322.69 7 Aug 2026 $326.45 10 Aug 2026 $331.59 11 Aug 2026 $327.05 12 Aug 2026 $332.86 13 Aug 2026 $328.34 14 Aug 2026 $332.27 17 Aug 2026 $335.73 18 Aug 2026 $332.82 19 Aug 2026 $343.34 20 Aug 2026 $337.02 21 Aug 2026 $346.58 24 Aug 2026 $341.72 25 Aug 2026 $356.19 26 Aug 2026 $359.76 27 Aug 2026 $357.46 28 Aug 2026 $351.46 31 Aug 2026 $359.36 1 Sep 2026 $363.84 2 Sep 2026 $369.23 3 Sep 2026 $371.47 4 Sep 2026 $358.24 8 Sep 2026 $351.26 9 Sep 2026 $348.09 10 Sep 2026 $345.55 11 Sep 2026 $347.00 14 Sep 2026 $340.03 15 Sep 2026 $336.68 16 Sep 2026 $336.67 17 Sep 2026 $338.75 18 Sep 2026 $336.67 21 Sep 2026 $333.85 22 Sep 2026 $350.88 23 Sep 2026 $341.75 24 Sep 2026 $344.96 25 Sep 2026 $345.82 28 Sep 2026 $337.08 29 Sep 2026 $335.06 30 Sep 2026 $332.56 1 Oct 2026 $325.31 2 Oct 2026 $322.28 5 Oct 2026 $334.85 6 Oct 2026 $326.81 7 Oct 2026 $324.57 8 Oct 2026 $327.30 9 Oct 2026 $331.61 Krishnan Suma President, R&D Sold on a plan $5.50M 4 Dec 2025 · at $220.14 · 1.7% of stake Krishnan Krish S President and CEO Sold on a plan $5.50M 4 Dec 2025 · at $220.14 · 1.7% of stake Krishnan Krish S President and CEO Sold on a plan $5.50M 4 Dec 2025 · at $220.16 · 1.7% of stake Krishnan Suma President, R&D Sold on a plan $5.50M 4 Dec 2025 · at $220.16 · 1.7% of stake ROMANO KATHRYN Chief Accounting Officer Sold on a plan $3.40M 9 Feb 2026 · at $272.14 · 39.3% of stake ROSSI DINO A Director Sold at will $4.95M 19 Feb 2026 · at $261.41 · 19.4% of stake JANNEY DANIEL Director Sold on a plan $3.71M 24 Feb 2026 · at $268.34 · 12.9% of stake JANNEY DANIEL Director Sold on a plan $10.11M 24 Feb 2026 · at $266.88 · 100% of stake JANNEY DANIEL Director Sold on a plan $192.50K 25 Feb 2026 · at $275.00 · 0.7% of stake JANNEY DANIEL Director Sold on a plan $2.13M 26 Feb 2026 · at $275.63 · 8.3% of stake JANNEY DANIEL Director Sold on a plan $3.25M 27 Feb 2026 · at $275.59 · 13.9% of stake ROMANO KATHRYN Chief Accounting Officer Sold on a plan $200.70K 2 Mar 2026 · at $267.60 · 3.2% of stake Krishnan Krish S President and CEO Sold on a plan $6.58M 4 Mar 2026 · at $263.17 · 1.7% of stake Krishnan Suma President, R&D Sold on a plan $6.58M 4 Mar 2026 · at $263.21 · 1.8% of stake Thomas John Charles EVP, General Counsel Sold on a plan $193.90K 26 May 2026 · at $302.03 · 100% of stake Krishnan Suma President, R&D Sold on a plan $7.70M 4 Jun 2026 · at $308.11 · 1.8% of stake Krishnan Krish S President and CEO Sold on a plan $7.70M 4 Jun 2026 · at $308.12 · 1.7% of stake Thomas John Charles EVP, General Counsel Sold on a plan $347.27K 25 Jun 2026 · at $347.27 · 100% of stake ROSSI DINO A Director Sold at will $8.23M 14 Aug 2026 · at $329.12 · 33.3% of stake Krishnan Suma President, R&D Sold on a plan $8.98M 4 Sep 2026 · at $359.32 · 1.9% of stake Krishnan Krish S President and CEO Sold on a plan $8.98M 4 Sep 2026 · at $359.32 · 1.8% of stake
0 buys2 sales at will19 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Revenue
$389.13M
Net income
$204.83M
Free cash flow
$188.91M
Operating margin
41.5%
Net margin
52.6%
Return on equity
16.8%
Return on capital
13.2%
Debt to equity
0.00
Revenue growth, 1 yr
33.9%
EPS growth, 1 yr
128.0%

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
0K -32M FY20 Fiscal year 2020 Revenue $0.00 Net income $32.17M Margin n/a 0K -70M FY21 Fiscal year 2021 Revenue $0.00 Net income $69.57M Margin n/a 0K -140M FY22 Fiscal year 2022 Revenue $0.00 Net income $139.98M Margin n/a 51M 11M FY23 Fiscal year 2023 Revenue $50.70M Net income $10.93M Margin 21.6% 291M 89M FY24 Fiscal year 2024 Revenue $290.52M Net income $89.16M Margin 30.7% · growth +473.0% 389M 205M FY25 Fiscal year 2025 Revenue $389.13M Net income $204.83M Margin 52.6% · growth +33.9%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
4 Sep 2026 Krishnan Krish S
President and CEO
Sold on a plan $8.98M 1.8%
4 Sep 2026 Krishnan Suma
President, R&D
Sold on a plan $8.98M 1.9%
14 Aug 2026 ROSSI DINO A
Director
Sold at will $8.23M 33.3%
25 Jun 2026 Thomas John Charles
EVP, General Counsel
Sold on a plan $347.27K 100%
4 Jun 2026 Krishnan Krish S
President and CEO
Sold on a plan $7.70M 1.7%
4 Jun 2026 Krishnan Suma
President, R&D
Sold on a plan $7.70M 1.8%